
Haleon Pakistan Limited has announced a £3.58 million ($4.9 million) investment to expand and modernize its Panadol Liquid packaging line.
Read more: Nestlé Announces $60 Million Expansion Investment in Pakistan
Haleon Pakistan Limited has confirmed plans to invest £3.58 million ($4.9 million) in upgrading its Panadol Liquid packaging line, according to a disclosure made to the Pakistan Stock Exchange – PSX.
The company said the investment will focus on acquiring advanced packaging machinery, upgrading infrastructure, and enhancing quality control systems. A spokesperson noted, “This expansion reflects our commitment to ensuring reliable access to trusted healthcare products while strengthening our operations in Pakistan.”
The decision, cleared by Haleon’s board of directors, is expected to increase production capacity and improve operational efficiency to meet growing consumer demand.
Officials added that the investment is part of a long-term strategy to reinforce Haleon’s presence in the consumer healthcare segment and support future growth. Industry observers highlight that Panadol remains one of Pakistan’s most widely used pain relief brands, and the expansion will help the company maintain its leadership in the market.
